#70Official Top 100
RAAS Blood Products
上海莱士血液制品股份有限公司
#70
Vaccines and blood productsHeparin and plasma products
Manufacturing profile
Vaccines and blood products
Heparin and plasma products
Region: Shanghai
Selection basis
The company is included in the official 2024 ranking of the 100 largest Chinese pharmaceutical-industry enterprises by main-business revenue.
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Representative manufacturing and QC chain
- 1Biological inputs or plasma pooling
- 2Purification and viral-clearance stages
- 3Formulation and adjuvant/protein control
- 4Sterile filling or lyophilisation
- 5Potency, sterility, endotoxin and cold chain
- 6Raw-material receipt and identification
- 7Dispensing, blending and granulation
- 8Tableting, encapsulation or solution preparation
- 9Packaging and labelling
Relevant FUZKK packages
Product/API utilities
Vaccine Potency AssessorAdjuvant Aluminum Assay CheckerAdjuvant Adsorption Efficiency Quality CheckerInactivated Vaccine Safety Test Quality CheckerLive Attenuated Vaccine Genetic Stability Quality CheckerPlasma Pool Traceability CheckerPlasma Viral Clearance Evidence CheckerCold Chain Shipping Temperature And MKT Quality CheckerHeparin Sodium Quality CheckerResidual Solvent Detergent Checker
Lumex — instrumental QC
LabEx — laboratory QC
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand the scope.
Mapping boundary
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Methodology